Table 1. Baseline characteristics.
| Characteristic | Patients (N=26) |
|---|---|
| Age, median years (range) |
60 (34–73) |
|
Sex, n
(%) | |
| Male | 16 (62) |
| Female |
10 (38) |
|
Race,
n
(%) | |
| Caucasian | 22 (85) |
| African American | 3 (12) |
| Unknown |
1 (4) |
|
ECOG performance status,
n
(%) | |
| 0 | 15 (58) |
| 1 |
11 (42) |
|
Primary tumour type,
n
(%) | |
| Biliary tract | 6 (23) |
| NSCLC | 3 (12) |
| Salivary gland | 3 (12) |
| Bladder | 2 (8) |
| Breast | 2 (8) |
| Oesophagus | 2 (8) |
| Pancreas | 2 (8) |
| Adenocarcinoma of unknown primary | 1 (4) |
| Othera |
5 (19) |
|
Number of prior lines of chemotherapy,
n
(%) | |
| 0 | 5 (19) |
| 1 | 9 (35) |
| 2 | 11 (42) |
| 3 |
1 (4) |
|
Patients with prior taxane therapy,
n
(%) | |
| Paclitaxel | 7 (27) |
| Docetaxel | 2 (8) |
Abbreviations: ECOG=Eastern Cooperative Oncology Group; NSCLC=non-small cell lung cancer.
a
Other tumour types were anal cancer, colorectal cancer, head and neck cancer, thymic carcinoma, and melanoma.